Patent US4544630A successfully refreshed from Google Patents.
US4544630A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for specific determination of cholesterol in the presence of the HDL fraction in serum
Assignee: Roche Diagnostics GmbH
•
Filing: 1983-02-22
•
Granted: 1985-10-01
•
Expires: 2003-02-22
Abstract
Abstract The present invention provides a process for the specific determination of the cholesterol of the LDL fraction in the presence of the HDL fraction of the lipoproteins of serum by the action of cholesterol esterase for the liberation of the cholesterol and oxidation of the liberated cholesterol with cholesterol oxidase and oxygen with the formation of hydrogen peroxide and cholestenone and kinetic measurement of the change of one of the reaction components of the oxidase reaction, especially the formation of hydrogen peroxide, wherein the measurement is carried out in a predetermined period of time, the reaction solution having a tenside concentration of 0.01 to 1.5 mmol/liter, a cholesterol esterase concentration of 0.1 to 30 U/ml. and a pH value of 6.5 to 8.0. The present invention also provides a reagent for carrying out this process.
Inventors
- 👤 Joachim Ziegenhorn
- 👤 Albert Roder
- 👤 Knut Bartl
- 👤 Gunter Wehmeyer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 07:40
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/60
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
90 words
A process for specific determination of cholesterol present in the LDL serum fraction, in the presence of an HDL fraction of serum lipoproteins, comprising: (a) adding a serum sample to cholesterol esterase; (b) oxidizing cholesterol thus produced with cholesterol oxidase and oxygen, so as to form hydrogen peroxide and cholestenone, and (c) measuring kinetically the concentration of one of the components of (b), wherein said measurement is carried out in a predetermined period of time, so as to provide data allowing elimination of cholesterol background contributed by said HDL fraction.
Claim 2
Dependent Claim
90 words
A process for specific determination of cholesterol present in the LDL serum fraction, in the presence of an HDL fraction of serum lipoproteins, comprising: (a) adding a serum sample to cholesterol esterase; (b) oxidizing cholesterol thus produced with cholesterol oxidase and oxygen, so as to form hydrogen peroxide and cholestenone, and (c) measuring kinetically the concentration of one of the components of (b), wherein said measurement is carried out in a predetermined period of time, so as to provide data allowing elimination of cholesterol background contributed by said HDL fraction.
Claim 3
Dependent Claim
19 words
Process according to claim 1, wherein a non-ionic tenside is added in a concentration of 0.01 to 0.30 mmol/liter.
Claim 4
Dependent Claim
15 words
Process according to claim 2, wherein the non-ionic tenside concentration is 0.06 to 0.18 mmol/liter.
Claim 5
Dependent Claim
34 words
Process according to claim 1, wherein a tenside of the bile acid group is added in a concentration of 0.01 to 1.5 mmol/liter and a pH value of from 7.2 to 8.0 is maintained.
Claim 6
Dependent Claim
24 words
Process according to claim 4, wherein the tenside concentration is 0.05 to 1.10 mmol/liter and the pH value is maintained at 7.6 to 8.0.
Claim 7
Dependent Claim
29 words
Process according to claim 1, wherein a cationic tenside is used in a concentration of 0.02 to 0.80 mmol/liter and the pH value is maintained at 6.5 to 7.6.
Claim 8
Dependent Claim
24 words
Process according to claim 6, wherein the tenside concentration is 0.08 to 0.35 mmol/liter and the pH value is maintained at 6.8 to 7.2.
Claim 9
Dependent Claim
19 words
Process according to claim 1, wherein an anionic tenside is used in a concentration of 0.01 to 0.70 mmol/liter.
Claim 10
Dependent Claim
15 words
Process according to claim 8, wherein the anionic tenside concentration is 0.05 to 0.35 mmol/liter.
Claim 11
Dependent Claim
25 words
Process according to claim 1, wherein the measurement is carried out within a period of 0.5 to 15 minutes after the start of the reaction.
Claim 12
Dependent Claim
12 words
Process according to claim 1, wherein cholesteroloxidase from Nocardia erythropolis is used.
Claim 13
Dependent Claim
15 words
Process according to claim 1, wherein a cholesterol esterase from Candida or Pseudomonas is used.
Claim 14
Dependent Claim
35 words
Process according to claim 1 for the specific determination of the cholesterol of the LDL fraction in the presence of the HDL fraction of the lipoproteins of the serum, substantially as hereinbefore described and exemplified.
Claim 15
Dependent Claim
55 words
Reagent for carrying out the process according to claim 1, wherein it contains: 200 to 1000 U/liter cholesterol oxidase, 1000 to 3000 U/liter peroxidase, 2000 to 10,000 U/liter cholesterol esterase, 0.10 to 0.16 mmol/liter of tenside, 2 to 20 mmol/liter phenol, 0.5 to 3 mmol/liter 4-aminoantipyrine, 70 to 130 mmol/liter tris/HCl (pH 7.3 to 7.7).
Claim 16
Dependent Claim
35 words
The process of claim 15, wherein the reaction solution has tenside concentration of 0.01 to 1.5 mmol/liter, cholesterol esterase concentration of 0.1 to 30 U/ml, and a pH of from about 6.5 to about 8.0.
References Cited (Backward Citations)
US4226713A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-09-30 | 1989-04-01 | 1989-10-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-09-30 | 1993-04-01 | 1993-10-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-09-30 | 1997-04-01 | 1997-10-01 | $7700.00 | Window Closed / Lapsed |